These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35947813)

  • 21. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
    Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study.
    de Baat EC; Feijen EAM; Reulen RC; Allodji RS; Bagnasco F; Bardi E; Belle FN; Byrne J; van Dalen EC; Debiche G; Diallo I; Grabow D; Hjorth L; Jankovic M; Kuehni CE; Levitt G; Llanas D; Loonen J; Zaletel LZ; Maule MM; Miligi L; van der Pal HJH; Ronckers CM; Sacerdote C; Skinner R; Jakab Z; Veres C; Haddy N; Winter DL; de Vathaire F; Hawkins MM; Kremer LCM
    J Clin Oncol; 2023 Jan; 41(1):96-106. PubMed ID: 36075007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of heart failure in a population with type 2 diabetes versus a population without diabetes with and without coronary heart disease.
    Chen HF; Ho CA; Li CY
    Diabetes Obes Metab; 2019 Jan; 21(1):112-119. PubMed ID: 30091215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.
    Jones LW; Liu Q; Armstrong GT; Ness KK; Yasui Y; Devine K; Tonorezos E; Soares-Miranda L; Sklar CA; Douglas PS; Robison LL; Oeffinger KC
    J Clin Oncol; 2014 Nov; 32(32):3643-50. PubMed ID: 25311213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
    Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
    Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention.
    Andersson A; Näslund U; Tavelin B; Enblad G; Gustavsson A; Malmer B
    Int J Cancer; 2009 Apr; 124(8):1914-7. PubMed ID: 19165857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Akyea RK; Kontopantelis E; Kai J; Weng SF; Patel RS; Asselbergs FW; Qureshi N
    Heart; 2022 Jan; 108(1):37-45. PubMed ID: 34429368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
    Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
    Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
    de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
    J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
    Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late cardiotoxicity after treatment for Hodgkin lymphoma.
    Aleman BM; van den Belt-Dusebout AW; De Bruin ML; van 't Veer MB; Baaijens MH; de Boer JP; Hart AA; Klokman WJ; Kuenen MA; Ouwens GM; Bartelink H; van Leeuwen FE
    Blood; 2007 Mar; 109(5):1878-86. PubMed ID: 17119114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†.
    Daniëls LA; Krol AD; de Graaf MA; Scholte AJ; Van't Veer MB; Putter H; de Roos A; Schalij MJ; Creutzberg CL
    Ann Oncol; 2014 Jun; 25(6):1198-203. PubMed ID: 24692582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital Heart Disease and Risk of Cardiovascular Disease: A Meta-Analysis of Cohort Studies.
    Wang T; Chen L; Yang T; Huang P; Wang L; Zhao L; Zhang S; Ye Z; Chen L; Zheng Z; Qin J
    J Am Heart Assoc; 2019 May; 8(10):e012030. PubMed ID: 31070503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN.
    Li Y; Yatsuya H; Tanaka S; Iso H; Okayama A; Tsuji I; Sakata K; Miyamoto Y; Ueshima H; Miura K; Murakami Y; Okamura T
    J Atheroscler Thromb; 2021 Aug; 28(8):816-825. PubMed ID: 33041313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
    Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
    J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.